Changing of expression of the Microphthalmia-associated Transcription Factor (MITF) and the POU domain transcription factor BRN2 (POU3F2) have already been linked to the metastatic mechanism of phenotype switching in malignant melanoma [37]. This evidence concerns the gene POU3F2 and melanoma.